American Medical Association

SHERPA: White

People

  1. Marghoob
    Marghoob
  2. Halpern
    Halpern
  3. Morrow
    Morrow
  4. Busam
    Busam
  5. Abramson
    Abramson
  6. Brennan
    Brennan
  7. Offit
    Offit
  8. Coit
    Coit
  9. Morris
    Morris
  10. Lee
    Lee

Groups

  1. Department of Medicine (483)
  2. Survivorship Research (357)
  3. Surgery (347)
  4. Population Sciences Research Program (290)
  5. Solid Tumor Oncology Division (233)
  6. Division of Subspecialty Medicine (222)
  7. Epidemiology and Biostatistics (172)
  8. Dermatology (169)
  9. Dermatology Service (168)
  10. Melanoma Disease Management Team (128)
Search Within
Formats
  1. Journal Article (916)
  2. Editorial (89)
  3. Correspondence (56)
  4. Review (39)
  5. Research Letter (37)
  6. Conference Paper (9)
  7. Guidelines (9)
  8. Miscellaneous (6)
Groups
  1. Department of Medicine (483)
  2. Survivorship Research (357)
  3. Surgery (347)
  4. Population Sciences Research Program (290)
  5. Solid Tumor Oncology Division (233)
  6. Division of Subspecialty Medicine (222)

More Groups

People
  1. Ashfaq Marghoob (89)
  2. Allan Halpern (50)
  3. Monica Morrow (46)
  4. Peter Bach (39)
  5. Klaus Busam (35)
  6. David Abramson (33)

More People

Years
  1. 2025 (30)
  2. 2024 (69)
  3. 2023 (63)
  4. 2022 (56)
  5. 2021 (75)
  6. 2020 (72)

More Years

Publications
  1. JAMA Oncology (321)
  2. JAMA - Journal of the American Medical Association (246)
  3. JAMA Dermatology (110)
  4. Archives of Dermatology (86)
  5. JAMA Surgery (77)
  6. Archives of Surgery (73)

More Publications

Results (1161)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Watch and wait in rectal cancer or more wait and see?
    Editorial

    Smith, J. J.; Paty, P. B.; Garcia-Aguilar, J.
    JAMA Surgery (2020)

    Fulltext@MSK | Save
  • Assessing the number of candidates there are for active surveillance of low-risk papillary thyroid cancers in the US
    Research Letter

    Roman, B. R.; Gupta, P.; Tuttle, R. M.; Morris, L. G. T.; Lohia, S.
    JAMA Otolaryngology - Head and Neck Surgery (2020)

    Fulltext@MSK | Save
  • Prognostic gene expression profiling in cutaneous melanoma: Identifying the knowledge gaps and assessing the clinical benefit
    Review

    Grossman, D.; Okwundu, N.; Bartlett, E. K.; Marchetti, M. A.; Othus, M.; Coit, D. G.; Hartman, R. I.; Leachman, S. A.; Berry, E. G.; Korde, L.; more...
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Missed opportunities on emergency remdesivir use
    Editorial

    Sarpatwari, A.; Kaltenboeck, A.; Kesselheim, A. S.
    JAMA - Journal of the American Medical Association (2020)

    Fulltext@MSK | Save
  • Performance of gene expression profile tests for prognosis in patients with localized cutaneous melanoma: A systematic review and meta-analysis
    Journal Article

    Marchetti, M. A.; Coit, D. G.; Dusza, S. W.; Yu, A.; McLean, L.; Hu, Y.; Nanda, J. K.; Matsoukas, K.; Mancebo, S. E.; Bartlett, E. K.
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Assessment and treatment outcomes of persistent radiation-induced alopecia in patients with cancer
    Journal Article

    Phillips, G. S.; Freret, M. E.; Novetsky Friedman, D.; Trelles, S.; Kukoyi, O.; Freites-Martinez, A.; Unger, R. H.; Disa, J. J.; Wexler, L. H.; Tinkle, C. L.; more...
    JAMA Dermatology (2020)

    Fulltext@MSK | Save
  • Incidence of opioid-associated deaths in cancer survivors in the United States, 2006-2016: A population study of the opioid epidemic
    Journal Article

    Chino, F.; Kamal, A.; Chino, J.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • De-escalating breast cancer surgery for low-risk ductal carcinoma in situ - In reply
    Correspondence

    Morrow, M.; Winer, E.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Assessment of racial differences in rates of autopsy in the US, 2008-2017
    Research Letter

    Gupta, A.; Premnath, N.; Kuo, P. L.; Sedhom, R.; Brawley, O. W.; Chino, F.
    JAMA Internal Medicine (2020)

    Fulltext@MSK | Save
  • Effect of osimertinib and bevacizumab on progression-free survival for patients with metastatic EGFR-mutant lung cancers: A phase 1/2 single-group open-label trial
    Journal Article

    Yu, H. A.; Schoenfeld, A. J.; Makhnin, A.; Kim, R.; Rizvi, H.; Tsui, D.; Falcon, C.; Houck-Loomis, B.; Meng, F.; Yang, J. L.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save